These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37575320)

  • 1. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
    Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
    Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
    Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
    Front Oncol; 2022; 12():753234. PubMed ID: 35280736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
    Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.
    Xia H; Zhang W; Zhang Y; Shang X; Liu Y; Wang X
    Front Oncol; 2022; 12():978069. PubMed ID: 36330494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis.
    Shao Y; Cao W; Gao X; Tang M; Zhu D; Liu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31113. PubMed ID: 36316884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
    Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
    Front Oncol; 2022; 12():962173. PubMed ID: 36059629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
    Li P; Lai Y; Tian L; Zhou Q
    Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
    Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
    Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
    Oku Y; Toyokawa G; Wakasu S; Kinoshita F; Takamori S; Watanabe K; Haratake N; Nagano T; Kosai K; Takada K; Fujimoto A; Higashijima K; Shiraishi Y; Tanaka K; Takeoka H; Okamoto M; Yamashita T; Shimokawa M; Shoji F; Yamazaki K; Okamoto T; Seto T; Ueda H; Takeo S; Nakashima N; Okamoto I; Takenaka T; Yoshizumi T
    Cancer Med; 2023 Jul; 12(13):14327-14336. PubMed ID: 37211905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors.
    Yan X; Liu P; Li D; Hu R; Tao M; Zhu S; Wu W; Yang M; Qu X
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109383. PubMed ID: 36330916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
    Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
    Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
    Wu M; Zhu Y; Chen X; Wang X; Lin X; Yan X; Mo P; Ye Y; Zeng Y; Yang Y; Fu Z
    J Gastrointest Oncol; 2023 Feb; 14(1):54-63. PubMed ID: 36915449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors.
    Wang J; Guo H; Yang J; Mao J; Wang Y; Yan X; Guo H
    Front Oncol; 2024; 14():1339729. PubMed ID: 38390262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Role of Pretreatment Prognostic Nutritional Index in Advanced Lung Cancer Patients Receiving First-Line Immunotherapy: A Meta-Analysis.
    Yang J; Li H; Li L; Lv J
    Cureus; 2024 Jan; 16(1):e52720. PubMed ID: 38384634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis.
    Sun Q; Sun H; Wu N; Hu Y; Zhang F; Cong X
    Front Oncol; 2022; 12():976224. PubMed ID: 36185176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
    Chen X; Li Z; Zhou J; Wei Q; Wang X; Jiang R
    PeerJ; 2022; 10():e14566. PubMed ID: 36540802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.